First human test for new cancer pill begins
NCT ID NCT00463814
Summary
This is a very early study to check if a new cancer drug called AZD6244, given as a capsule, is safe and how it moves through the body. It involved 58 adults with advanced solid tumors that had not responded to standard treatments. The main goal was to find the right dose and understand side effects, not to test how well it fights cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Utrecht, 3584 CX, Netherlands
-
Research Site
Sutton, SM2 5PT, United Kingdom
-
Research Site
Aurora, Colorado, 80045, United States
-
Research Site
Nijmegen, 6525 GA, Netherlands
Conditions
Explore the condition pages connected to this study.